Sexual Function and Quality of Life After LEEP: A Prospective Multi-Center Study

Trial Title: Sexual Function and Quality of Life After LEEP: A Prospective Multi-Center Study

NCT ID: NCT06078514

Condition: Cervical Dysplasia

Conditions: Official terms:
Uterine Cervical Dysplasia

Conditions: Keywords:
Colposcopy
LEEP
Cervical dysplasia
HSIL
Sexual function index
Health-related quality of life

Study type: Observational [Patient Registry]

Overall status: Not yet recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Procedure
Intervention name: Loop electrosurgical excision procedure (LEEP)
Description: The affected area of cervix is excised under local anesthesia using a small thin electrically charged hardwire loop for simultaneous cutting and electrocoagulation.
Arm group label: Loop electrosurgical excision procedure (LEEP)

Other name: Large loop excision of the transformation zone (LLETZ)

Summary: The goal of this prospective study is to investigate the sexual function and quality of life of women undergoing loop electrosurgical excision procedure (LEEP) due to HPV-related cervical lesion. The main question it aims to answer are: - Whether LEEP affects the sexual function of women in comparison to untreated women, and - Whether LEEP affects the health-related quality of life of women in comparison to untreated women Participants are asked to complete web based an international validated self-report questionnaire on sexual function issues, the Female Sexual Function Index (FSFI), and a validated quality of life -questionnaire 15D at the time of first colposcopy appointment and six and 24 months, 3 years and 5 years after index visit (LEEP or first colposcopy in control group). Relevant additional background information is also collected via questionnaire and from patient files. Researchers will compare women with LEEP and those with only colposcopy visits to see any differences between self-reported sexual function (FSFI scores) or health-related quality of life (15D scores) both short and long-term.

Detailed description: We plan to recruit minimum of 1000 women referred to colposcopy in Tampere University Hospital, Helsinki University Hospital, Kuopio University Hospital, Oulu University Hospital, North Karelia Central Hospital and Hyvinkää Hospital to our prospective multi-center study. Recruitment is done at gynecology outpatient clinics of the participating units at the first colposcopy visit, where the doctor performing the colposcopy informs the eligible women about the study, gives them the patient information letter, and asks them to participate and, if they agree, to fill in the informed consent. We aim to recruit 500 women undergoing LEEP (intervention arm) and at least 500 undergoing only colposcopy (control arm). Pirkanmaa Hospital District Ethical Review Board has approved the study design and local scientific committees in each university hospital area applied for permission to launch the study. In each participating unit, eligible women will be given a written patient information sheet on the study and asked to participate. From women willing to participate, a written informed consent will be collected and stored in locked cabinet in participating unit. These documents will be accessed only by study members. Participants are contacted due to the study 5 times: at the time of recruitment, 6 months after the index visit (either first colposcopy or LEEP visit) and 24 months, 3 years and 5 years after the index visit. Each time they are asked to fill in the same questionnaires, sent by mail and available also web based. No additional visits are needed, nor any extra samples taken. The study data is collected using REDCap system designed for safe patient data management. Access to the system is strictly restricted to the research team members, that are committed to handle the data according to good clinical practice. At the end of the study, the digital data is to be stored at Pirkanmaa Hospital Disctrict official research files, where individual patient data will be available only for identified study members. In the analysis the data will be used pseudonymized. Informed consents will be stored in participating research units.

Criteria for eligibility:

Study pop:
The study population consists of adult, sexually active, non-pregnant, 18-70 year-old women referred to gynecology outpatient clinics of the participating units for colposcopy due to cytological changes or repeated HPV positivity.

Sampling method: Non-Probability Sample
Criteria:
Inclusion Criteria: - Age 18 to 70 years - First colposcopy visit (in 24 months, if previous colposcopies) - Referral for cytological changes or repeated HPV positivity - No previous LEEP or other operations affecting the length of cervix - Not pregnant at the time of colposcopy/LEEP - Sexually active - Capable of understanding the study protocol - informed consent given - Fluent in Finnish Exclusion Criteria: - Age less than 18 or more than 70 years - Previous colposcopy within 24 months - Referral for other reason, e.g. vulvar lesion - Previous LEEP or other operation affecting the length of cervix - Pregnant at the time of colposcopy/LEEP - Sexually inactive - Unable to understand the study protocol - no informed consent - Difficulties in understanding Finnish

Gender: Female

Gender based: Yes

Gender description: Female by birth

Minimum age: 18 Years

Maximum age: 70 Years

Healthy volunteers: Accepts Healthy Volunteers

Locations:

Facility:
Name: Tampere University Hospital

Address:
City: Tampere
Country: Finland

Contact:
Last name: Karolina Louvanto, Prof.
Email: karolina.louvanto@tuni.fi

Start date: December 2023

Completion date: December 2030

Lead sponsor:
Agency: Tampere University Hospital
Agency class: Other

Collaborator:
Agency: Tampere University
Agency class: Other

Collaborator:
Agency: Helsinki University Central Hospital
Agency class: Other

Collaborator:
Agency: University of Helsinki
Agency class: Other

Collaborator:
Agency: Kuopio University Hospital
Agency class: Other

Collaborator:
Agency: Oulu University Hospital
Agency class: Other

Collaborator:
Agency: Hyvinkää Hospital
Agency class: Other

Collaborator:
Agency: North Karelia Central Hospital
Agency class: Other

Source: Tampere University Hospital

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06078514